Treatment of keloids using injections
Official title: Vitamin D in Keloids
Run by Sohag University · NCT06729840 · Data updated 2026-11-12
This study is testing if injections can help reduce keloids in adults aged 18 to 60.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 45 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Status | Recruiting |
| Started | December 1, 2024 |
| Main results expected | April 1, 2025 |
| Study ends | May 2, 2025 |
| Registry record updated | December 11, 2024 |
| Trial ID | NCT06729840 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 60 with keloids.
✕Probably not a fit
Patients who are pregnant, lactating, or have other skin diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of intralesional injections for treating keloids in patients aged 18 to 60. A total of 45 participants will be divided into three groups, with follow-up assessments conducted before each injection session and three months after the final session. Evaluations will include photographic assessments, scoring, and dermoscopy to measure treatment outcomes.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce the size and appearance of keloids, improving patients' quality of life.
How similar studies have gone: Previous studies have shown promising results with intralesional treatments for keloids, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Both sex aged 18-60 having keloid \- Exclusion Criteria: * pregnancy , lactation Skin disease
Where it's running
-
Sohag university hospital
Sohag, Egypt Recruiting
Study contacts
- Study coordinator: sama alaa, resident doctor
- Email: samaalaa.867@gmail.com
- Phone: 01027748791
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using stem cells from umbilical cords to improve healing of skin graft donor sites
This study is testing whether using stem cells from umbilical cords can help people heal better and faster from skin graft donor sites compared to standard treatment.
-
Trauma registry at Sohag University Hospital
This study tests the creation of a trauma registry in the emergency department to collect data on injured adults admitted with polytrauma at Sohag University Hospital.
-
Prevalence of Myocardial Bridging and its relation to Coronary Plaques on MDCT
This study tests how common myocardial bridging is and whether it relates to coronary plaque in patients undergoing coronary CT angiography.
-
Septoplasty: see if it changes headache symptoms
This study tests whether septoplasty can change headache severity in adults with septal deviation and headache.
-
Predicting SLE Flares with Patient Reports and Machine Learning
Aims to test a low-cost, patient-reported outcome–based machine learning tool to see if it can detect lupus flares early and support care, especially in settings with limited resources.
-
Is geographic mismatch linked to short-term major heart problems after long drug-eluting stent placement?
This study checks whether geographic mismatch can predict short-term major adverse cardiovascular events after a long drug-eluting stent is placed in the coronary arteries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.